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An Overlapping Case of Lupus Nephritis and IgG4-Related 
Kidney Disease
Mazen Zaaroura, c, Chanudi Weerasinghea, Ahmad Eterb, Suzanne El-Sayeghb, Elie El-Charabatyb
Abstract
We report a case of a 71-year-old Filipino female who was admitted 
to the hospital for abdominal pain, vomiting and diarrhea of 8 days 
duration. The patient was found to have marked acute kidney injury 
(AKI), which required hemodialysis in the next 3 days. Extensive 
workup revealed hematuria, subnephrotic range proteinuria, elevated 
anti-nuclear antibody (ANA) and elevated total immunoglobulin G 
(IgG) levels, with normal IgG4 and anti-dsDNA levels. On kidney 
biopsy, mild membranous glomerulonephritis was found, along with 
autoimmune tubulointerstitial nephritis (TIN) with a “full-house” pat-
tern of immune deposits. These findings were suggestive of lupus in-
terstitial nephritis. However, IgG4+ plasma cells were detected in the 
interstitium by immunostaining, favoring a diagnosis of IgG4-related 
kidney disease (IgG4-RKD). Our case highlights the difficulty in dif-
ferentiating lupus nephritis (LN) from IgG4-RKD in some patients, 
raising the suspicion that these two entities can co-exist.
Keywords: IgG4-related kidney disease; Lupus nephritis; Tubuloint-
erstitial nephritis; Membranous nephropathy; IgG4-related tubuloint-
erstitial nephritis
Introduction
Systemic lupus erythematosus (SLE) is a chronic multi-organ 
disease with a variable clinical presentation. Kidney involve-
ment is seen in half of these patients and remains the leading 
cause of death [1]. All renal compartments including glomeru-
lar, tubulointerstitial, and vascular components may be affect-
ed [2], and the renal biopsy remains essential for classification, 
prognosis and management of lupus nephritis (LN) [3].
Immunoglobulin G4-related kidney disease (IgG4-RKD) 
is a recently recognized disorder, the hallmark of which is 
dense lymphoplasmacytic infiltrate rich in IgG4+ plasma cells 
with interstitial fibrosis [4]. The most dominant feature of the 
disease is tubulointerstitial nephritis (TIN), although other glo-
merular lesions, such as membranous nephropathy, can be seen 
[4].
In most cases, the combination of clinical and serological 
features, supported by findings on kidney biopsy, is enough to 
establish a definitive diagnosis of either LN or IgG4-RKD. We 
report a challenging case where the complete distinction be-
tween these two entities was not possible, raising the suspicion 
of an overlap syndrome.
Case Report
Clinical history and initial laboratory data
A 71-year-old Filipino female presented to our hospital with 
abdominal pain, vomiting and diarrhea. The patient had been 
well until 8 days before admission, when the abdominal pain 
developed. The pain was diffuse, intermittent, and associated 
with episodes of vomiting and non-bloody diarrhea. Review of 
systems was negative except for minimal shortness of breath 
on exertion with no other respiratory symptoms. Prior medical 
history included hypertension treated with valsartan, hypothy-
roidism treated with levothyroxine, and thymoma resection. 
The patient was a non-smoker and had allergies to penicillin 
and amlodipine. Family history was non-contributory.
On admission, the patient’s body temperature was 99 °F, 
blood pressure was 128/78 mm Hg, and heart rate was 104/
min. Physical exam was only remarkable for epigastric ten-
derness and mild bilateral lower extremity pitting edema. The 
patient was found to have marked leukocytosis of 44.0 × 109/L 
(77% segmented neutrophils, 10% bands), along with acute 
kidney injury (AKI) with a blood urea nitrogen (BUN) of 88 
mg/dL and a serum creatinine of 9.65 mg/dL (her baseline cre-
atinine 2 years prior was 1.2 mg/dL). Hematologic findings 
were as follows: hemoglobin 11.7 g/dL, platelet count 255 × 
109/L, erythrocyte sedimentation rate (ESR) 61 mm/h. Aside 
from AKI and hypoalbuminemia, blood chemistry tests, in-
cluding liver and pancreatic enzymes, were normal.
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The patient denied any change in urine output or color, 
and no urinary symptoms. She also had no skin changes, oral 
ulcers, dry eyes or mouth, photosensitivity, arthralgias or up-
per respiratory symptoms. She reported no recent change in 
medications and no over the counter supplements.
Given the kidney injury, the valsartan was discontinued, 
intravenous fluids were started and a Foley catheter was placed 
to monitor her urine output. Analysis of the urine revealed 
blood with 12 - 20 red blood cells per high-power field, 6 - 
12 white blood cells per high-power field and proteinuria of 
2.6 g/day. Few white blood cells casts were seen with no red 
blood cells casts. A renal sonogram and a non-contrast abdom-
inal computed tomography (CT) scan were inconclusive with 
normal kidney size (10.7 and 11.9 cm). A chest radiograph 
showed a right-sided upper lobe opacity. A chest CT confirmed 
the opacity and also demonstrated multiple small right-sided 
upper lobe granulomas of unclear etiology.
The admitting diagnosis was sepsis secondary to a pre-
sumed pneumonia, complicated by AKI, for which antibiotics 
were started. The kidney injury was initially attributed to se-
vere pre-renal disease (from vomiting/diarrhea and sepsis) or 
acute tubular necrosis (ATN). The infectious workup was non-
diagnostic, as evidenced by negative cultures (blood, stool, 
urine and later bronchoalveolar lavage smear for acid fast and 
cultures), quantiferon and urine streptococcal and legionella 
antigens.
The kidney function failed to improve with intravenous 
hydration (Table 1), and hemodialysis was initiated on day 4 
Table 1.  Evolution of BUN and Creatinine Over Days
Day Admission Day 2 Day 3 Day 4 Day 5 Day 6
BUN (mg/dL) 88 100 100 105 82 40
Creatinine (mg/dL) 9.65 9.27 9.20 9.70 9.0 5.80
Table 2.  Laboratory Findings
Parameter Value
Creatinine (mg/dL) 9.65
BUN (mg/dL) 88
Total protein (g/dL) 6.10
Albumin (g/dL) 2
Thyroid stimulating hormone (TSH) (µIU/mL) 0.81
Hepatitis B surface antigen (HbsAg) Reactive
IgM hepatitis B core antibody Non-reactive
Hepatitis B viral DNA (copies) 22576
Urinary protein (g/day) 2.60
ESR (mm/h) 61
Antinuclear antibody (ANA) 1:320, homogeneous
Antineutrophil cytoplasmic antibody (ANCA) Negative
Complement C3 (mg/dL) 100 (reference range 80 - 180)
Complement C4 (mg/dL) 11 (reference range 10 - 45)
Anti-SSA antibody Negative
Anti-SSB antibody Negative
Anti-RNP antibody Negative
Anti-dsDNA antibody Negative
Smith antibody (anti-Sm) Negative
IgG1 (mg/dL) 1230 (reference range 382 - 929)
IgG2 (mg/dL) 735 (reference range 241 - 700)
IgG3 (mg/dL) 418 (reference range 22 - 178)
IgG4 (mg/dL) 37.10 (reference range 4 - 86)
Serum protein electrophoresis (SPEP) Normal
Glomerular basement membrane antibody (anti-GBM) Negative
Cryoglobulin Negative
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for worsening uremia. Extensive workup for the kidney dis-
ease revealed elevated anti-nuclear antibody (ANA) titer, low-
normal complement C4 level, reactive hepatitis B surface an-
tigen (HBsAg), and elevated IgG levels. An immunoglobulin 
subclass analysis of peripheral blood revealed elevated levels 
of IgG1, IgG2, IgG3, along with normal IgG4 level. Additional 
studies were all negative (Table 2). Given the presence of he-
maturia, subnephrotic proteinuria, and worsening kidney func-
tion, a renal biopsy was scheduled.
Kidney biopsy
A CT-guided core needle biopsy of the right kidney was per-
formed. The specimen submitted for light microscopy ex-
hibited a total of 11 glomeruli, four of which were globally 
sclerotic. The remaining glomeruli appeared normal in size 
with patent capillaries. There was mild segmental to global 
increase in mesangial cell number and matrix. The glomeru-
lar basement membrane (GBM) appeared mildly thickened 
(Fig. 1A). Trichrome and silver stains delineated minute 
subepithelial fuchsinophilic deposits that focally indent the 
GBM, consistent with membranous features; however, no 
well-developed GBM spikes were seen. No glomeruli with 
neutrophil infiltration, overt endocapillary proliferation, ne-
crotizing features or cellular crescents were identified. Vir-
tually 100% of the cortex sampled had interstitial expansion 
by a mixture of fibrosis and edema associated with a patchy 
moderate inflammatory infiltrate of numerous plasma cells, 
lymphocytes, monocytes and occasional neutrophils. Tubular 
atrophy affected approximately 50% of the cortex sampled. 
The remaining tubules displayed diffuse acute injury with 
epithelial simplification (Fig. 1B), loss of brush border and 
enlarged reparative nuclei containing nucleoli. Many tubular 
basement membranes appeared thickened by PAS positive 
material. There also was mild arterio- and arteriolosclerosis, 
but no arteritis was identified.
Immunoperoxidase staining for IgG4 revealed up to 13 
IgG4+ plasma cells per high-power field in the areas of most 
intense interstitial inflammation (Fig. 1C, D), suggestive of 
IgG4-related TIN. Immunostaining for phospholipase A2 re-
ceptor (PLA2R) antibody was negative.
Immunofluorescence (IF) microscopy (Fig. 2) showed 
granular global mesangial and irregular capillary wall positiv-
ity in a predominantly sub-epithelial distribution. Abundant tu-
bular basement membrane granular deposits also were found, 
staining for a “full-house” of immune reactants (Table 3), and 
suggestive of LN.
By electron microscopy, none of the two glomeruli sam-
pled showed global or segmental sclerosis. The glomeruli dis-
played mild segmental increase in mesangial cell number and 
matrix containing small paramesangial electron dense depos-
Figure 1. Light microscopy (A, B) shows: (A) mildly thickened glomerular basement membrane and (B) diffuse acute tubular in-
jury with epithelial simplification consistent with acute tubular necrosis (ATN). Immunoperoxidase staining (C, D): immunostaining 
for IgG4 shows IgG4 positive plasma cells in the interstitium. 
Figure 2. Immunofluorescence (IF) showing (A) granular glomerular capillary wall staining 2+ for IgG and (B) granular diffuse 
tubular basement membranes staining 2+ for IgG. 
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its. The peripheral glomerular capillary walls were irregularly 
thickened by the presence of scattered small subepithelial and 
intramembranous deposits that range from electron dense to 
electron lucent, consistent with focal resorption. Overall, foot 
process effacement involved approximately 50% of the glo-
merular capillary surface area. No endothelial tubuloreticular 
inclusions (TRIs) were seen. Abundant granular electron dense 
deposits were seen involving the tubular basement membranes, 
associated with tubular atrophy, interstitial fibrosis, inflamma-
tion and edema.
In summary, the biopsy showed ATN, mild membranous 
glomerulonephritis, and severe autoimmune TIN with abun-
dant tubular basement membrane deposits.
Diagnosis
IgG4-related TIN with membranous nephropathy, and/or lupus 
membranous nephritis with TIN.
Clinical follow-up
Although no definitive diagnosis was reached, the patient was 
started, the day after biopsy, on intravenous methylprednisone 
1 g/day for 3 days, followed by prednisone 60 mg/day. She did 
not tolerate the glucocorticoid therapy and developed two epi-
sodes of gastrointestinal bleed, the second one severe enough 
to require distal gastrectomy. She was switched to mycophe-
nolate mofetil (MMF) and was discharged home after a hos-
pitalization of 33 days. She was seen on multiple occasions at 
the nephrology clinic and was successfully taken off hemodi-
alysis 2 months later. After 5 months of immunosuppressive 
therapy, her creatinine level was 1.6 mg/dL and her proteinuria 
was 550 mg/day. More impressively, almost a year after her 
admission, her creatinine is currently back to her baseline level 
of 1.2 mg/dL and her proteinuria was as low as 427 mg/day. 
Complements, IgG4 and anti-dsDNA levels remained normal 
after 1 year. She also failed to show any clinical manifestation 
of SLE, aside from the nephropathy.
Discussion
SLE is a chronic immune-mediated disease that can affect 
almost any organ system. Although overall mortality from 
this condition has decreased, nephropathy remains the lead-
ing cause of death [1]. The term “LN” is mainly used to refer 
to the immune complex-mediated glomerulonephritis [2]. The 
renal involvement in SLE has diverse morphologic manifes-
tations with varying clinical presentations and consequences. 
The disease is staged according to the classification revised by 
Table 3.  Immunofluorescence Results
Glomeruli Tubules Interstitium Vessels
IgG 3 gloms 2+
Gran global mes
Gran diffuse
TBM’s 2+
Sparse GCW
Neg Neg
IgM 3 gloms 1+
Gran global mes
Sparse GCW
TBM’s 1+
Gran focal
Plasma cells +1
cytoplasm
Neg
IgA 3 gloms 1+
Gran global mes
Sparse GCW
TBM’s 1+
Gran focal
Plasma cells +1
cytoplasm
Neg
C3 3 gloms 1+
Gran global mes
Sparse GCW
TBM’s 1+
Gran diffuse
Neg Neg
C1 3 gloms neg TBM’s 1+
Gran focal
Neg Neg
FBGN 3 gloms neg Neg 2+ Neg
ALB 3 gloms neg Neg Neg Neg
KAPPA 3 gloms 2+
Gran global mes
Sparse GCW
TBM’s 2+
Gran diffuse
Plasma cells
+1
cytoplasm
Neg
LAMDA 3 gloms 2+
Gran global mes
Sparse GCW
TBM’s 2+
Gran diffuse
Plasma cells +1
cytoplasm
Neg
Immunofluorescence results showing granular global mesangial and irregular capillary wall, as well as abundant tubular base-
ment membrane granular deposits staining for a “full-house” of immune reactants (deposits containing IgM, IgA, IgG, Kappa, 
Lamda, C3 and C1). gloms: glomeruli; Gran: granular; mes: mesangial; GCW: glomerular capillary wall; TBM: tubular basement 
membrane; Neg: negative; FBGN: fibrinogen; ALB: albumin.
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the International Society of Nephrology (ISN) and the Renal 
Pathology Society (RPS) in 2003. This classification is based 
on light microscopy, IF, and electron microscopy findings from 
renal biopsy specimens [3].
IgG4-RKD is a fibro-inflammatory condition, the hall-
mark of which is dense lymphoplasmacytic infiltrates rich in 
IgG4+ plasma cells, storiform interstitial fibrosis and elevated 
serum IgG4 concentration [4]. It is part of a wider entity called 
IgG4-related disease (IgG4-RD), which is a well-defined sys-
temic disease characterized by abundant IgG4+ plasma cell 
infiltration into the tissues [5]. The first recognized form of 
IgG4-RD was sclerosing pancreatitis, described in 1961 by 
Sarles et al [6], and later labeled as autoimmune pancreatitis 
(AIP). Since then, IgG4-RD has been described in nearly every 
organ system [5, 7, 8]. IgG4-RKD was first reported as a an 
extrapancreatic manifestation of AIP [9, 10], but recently it 
has been described in patients without pancreatitis [11, 12]. 
The most common pattern found on renal biopsy is IgG4-TIN 
[13, 14]. Glomerular lesions can also be seen, including mem-
branous nephropathy (the most common glomerular lesion), 
membranoproliferative glomerulonephritis, and mesangial 
proliferative glomerulonephritis [4, 15-17].
The patient described in our case presented with marked 
kidney injury of unknown duration. The combination of mi-
croscopic hematuria and subnephrotic range proteinuria was 
suggestive of an underlying glomerular disease. An additional 
tubular involvement was suggested by the presence of white 
blood cells casts. The initial impression was that of an anti-
neutrophil cytoplasmic antibody-associated (ANCA-associat-
ed) vasculitis, given the patient’s age and associated lung le-
sions. Additional pertinent serologic tests included a positive 
ANA, a low-normal complement C4 level, and an elevated to-
tal IgG level, all of which confirmed the suspicion of an auto-
immune systemic process, but were non-specific for a particu-
lar disease. Given the rapid worsening of the kidney function, 
in the setting of a suspected vasculitis, the decision to perform 
a renal biopsy was made.
Kidney biopsy revealed mild membranous glomerulone-
phritis and severe autoimmune TIN, a combination of findings 
seen in both LN and IgG4-RKD. In the setting of an immune 
complex-mediated glomerulonephritis, some pathological 
findings on the biopsy strongly suggest a diagnosis of LN 
including 1) “full-house” IF staining for IgG, IgM, IgA, C3 
and C1q; 2) extraglomerular immune deposits; 3) combined 
mesangial, subendothelial and subepithelial immune deposits 
and 4) the presence of endothelial TRIs [18, 19]. Our patient 
had all of these pathological findings, with the exception of 
the TRI, making the histological diagnosis of membranous 
lupus nephritis associated with severe lupus interstitial ne-
phritis more likely than IgG4-RKD. On the other hand, immu-
nostaining for IgG4 revealed up to 13 IgG4+ plasma cells per 
high-power field, favoring a diagnosis of IgG4-TIN. Immu-
nostaining for phospholipase A2 receptor antibody, a marker 
of primary membranous glomerulopathy [20], was negative, 
labeling the membranous nephropathy as most likely due to 
a “secondary” injury. Furthermore, even though HBsAg was 
detected in the serum, the presence of auto-immune interstitial 
nephritis argues against the possibility of hepatitis B associated 
membranous nephritis. It is also likely that recent diarrhea and 
intravascular volume depletion have contributed to the acute 
tubular injury from ischemia, producing a superimposed ATN.
The diagnosis of SLE is based on a combination of clinical 
findings and laboratory evidence. The presence of four of the 
11 American College of Rheumatology (ACR) criteria yields 
a sensitivity of 85% and a specificity of 95% for SLE [21]. 
When the Systemic Lupus International Collaborating Clinics 
(SLICC) group revised and validated the ACR SLE classifica-
tion criteria in 2012, they classified a person as having SLE in 
the presence of biopsy-proven LN with ANA or anti-dsDNA 
antibodies or if four of the diagnostic criteria, including at least 
one clinical and one immunologic criterion, have been satis-
fied [22]. Our patient had only two SLICC diagnostic criteria 
(a positive ANA and renal involvement, and arguably a low-
normal complement C4 level), insufficient to establish SLE 
as a definitive diagnosis. Elevated ANA and anti-dsDNA an-
tibody titers along with depressed serum complement yield a 
combined sensitivity exceeding 90% for the diagnosis of SLE 
[23]. That being said, cases of lupus with a negative ANA/
anti-dsDNA antibody and/or normal serum complements have 
been reported, suggesting that seronegativity does not exclude 
the diagnosis [24, 25]. Similarly, the absence of systemic find-
ings of SLE does not exclude renal-limited lupus [26, 27]. 
The nephropathy in lupus includes a myriad of findings such 
as TIN and membranous nephropathy, both non-specific for 
the disease. However, the finding of a “full-house” pattern on 
IF favors the diagnosis of LN. In fact, the presence of “full-
house” pattern, despite being described in non-lupus patients 
[28], makes LN very likely, even in the setting of a negative se-
rology for SLE [29]. Furthermore, multiple reports described 
patients, mostly children, who presented initially with a “full-
house” nephropathy, predicting the development of delayed 
clinical/serological SLE after a variable period of time [27, 
30-32].
While in the past decade many studies have described 
IgG4-RKD, a proposal on diagnostic approach has been only 
recently published. In 2011, diagnostic criteria for IgG4-TIN 
and a diagnostic algorithm, using a set of diagnostic criteria 
for IgG4-RKD, were proposed by the group of North America 
[33] and the Japanese Society of Nephrology [34], respective-
ly. According to the latter group, an elevated serum IgG4 level 
is required, making the diagnosis in our case “possible”, but 
not “definite”. On the other hand, our patient met the diag-
nostic criteria for IgG4-RKD set forth by the group of North 
America by having more than 10 IgG4+ plasma cells per 
high-power field (mandatory criterion), along with elevated 
total IgG levels. Radiographic features of the disease, such as 
low-attenuation renal lesions or diffuse marked enlargement 
of the kidneys [35], could not be adequately assessed given 
the non-contrast nature of the abdominal CT scan. Although 
other organ involvement was also not obvious, the presence 
of right-sided upper lobe granulomas can be part of IgG4-RD. 
Elevated total IgG level is prominent in many cases of IgG4-
RKD, but the elevation in the level of IgG4 subclass is the 
most important finding, present in more than 90% of patients 
[36]. To our knowledge, only two cases were published with 
typical features of the disease but with normal serum IgG4 lev-
els [37, 38], our case being the third described. Taken together, 
our patient could very likely have IgG4-RKD; however, an 
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increase in the number of IgG4+ plasma cells was found to 
be non-specific for IgG4-RD. In fact, it may also be a feature 
of ANCA-associated vasculitis, granulomatosis with polyan-
gitis, Churg-Strauss syndrome, lymphoproliferative disorders 
including malignant lymphoma, and even some inflammatory 
conditions [5, 39]. Moreover, Houghton et al have reported 
that IgG4+ plasma cell infiltration in the renal parenchyma 
may be evident even in some cases of diabetic nephropathy, 
idiopathic TIN, and even LN [39].
The mainstay of treatment for IgG4-RKD is glucocorti-
coids, with a dramatic and rapid response rate. There are no 
guidelines for the optimal dose and duration of treatment, and 
some patients might even relapse after discontinuation of im-
munosuppression [33]. Azathioprine, MMF, and methotrexate 
can be used as steroid-sparing drugs or to maintain remission. 
Similarly, a combination of prednisone and MMF is the stand-
ard-of-care treatment for severe LN [40, 41]. Although a de-
finitive diagnosis of either LN or IgG4-RKD was not reached 
in our case, we opted to treat our patient with MMF, as it is a 
common therapeutic option for both entities and our patient 
could not tolerate steroids. Her response to treatment was a 
remarkable one. In fact, her serum creatinine was back to her 
baseline level, along with a marked reduction in the proteinu-
ria.
In summary, we reported a challenging case where clini-
cal, laboratory and even pathologic findings were inconclusive 
for a definitive diagnosis. The patient described had features 
of both LN and IgG4-RKD. The kidney biopsy findings of 
“full-house” tubular basement membrane deposits supported 
the possibility of lupus interstitial nephritis, correlating with 
the positive ANA. However, in the absence of clinical findings 
suggestive of SLE along with the near normal complements 
and anti-dsDNA levels, the differential diagnosis included 
IgG4-TIN. This possibility is further supported by the findings 
of IgG4+ plasma cells in the interstitium, despite the normal 
serum IgG4 level. A similar report was published in the lit-
erature describing a “possible” IgG4-TIN concomitant with 
membranous nephropathy, where the absence of “definite” di-
agnosis was attributed to the difficulty differentiating findings 
from membranous lupus nephritis with severe tubulointersti-
tial changes [42]. Our case confirms the numerous clinical and 
histopathological similarities between LN and IgG4-RKD, and 
raises the possibility of an overlap syndrome. Further studies 
are warranted to address this concern, as well as establish a 
clinical/histological “marker” able to provide a definitive di-
agnosis of either entity.
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